Cover Image
市場調查報告書

NIPT (非侵入性產前檢查) 檢驗的全球市場

Global Non-Invasive Prenatal Testing (NIPT) Market - Analysis and Forecast 2017-2023: Focus on Test Type, Country Analysis (Test Volume & Value), APAC Countries by Test Type, Patent Landscape and Competitive Landscape

出版商 BIS Research 商品編碼 498155
出版日期 內容資訊 英文 224 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
NIPT (非侵入性產前檢查) 檢驗的全球市場 Global Non-Invasive Prenatal Testing (NIPT) Market - Analysis and Forecast 2017-2023: Focus on Test Type, Country Analysis (Test Volume & Value), APAC Countries by Test Type, Patent Landscape and Competitive Landscape
出版日期: 2017年04月30日 內容資訊: 英文 224 Pages
簡介

本報告提供全球NIPT (非侵入性產前檢查) 檢驗市場相關分析,檢驗方法的概要和主要的優點、缺點,主要的推動及阻礙市場要素,相關疾病概要,市場規模趨勢預測 (各檢驗方法、各地區),市場競爭現況與方向性,主要企業簡介等調查。

第1章 分析範圍、手法

第2章 市場概要

  • 簡介
  • NIPT的優點與風險
  • NIPT的技術性方法
    • FCMB (母體血液中胎兒細胞檢驗)
    • 無細胞NIPT檢驗
  • 專利環境
  • 全球產前檢查市場未來展望

第3章 市場動態

  • 推動市場要素
  • 市場課題
  • 市場機會

第4章 主要染色體非整倍體

第5章 競爭環境

  • 市場主要趨勢與策略
  • 市場向心力分析:各地區
  • 成長率佔有率、矩陣
  • 波特的五力分析
  • 價值鏈分析

第6章 全球NIPT市場:各檢驗手法 (以數量、金額為準)

  • 市場概要
  • Panorama檢驗
  • Sequenom檢驗
  • Harmony檢驗
  • NIFTY檢驗
  • verifi檢驗
  • IONA檢驗
  • Prena檢驗
  • BambniTest
  • 其他

第7章 全球NIPT市場:各地區 (以數量、金額為準)

  • 各地區的市場方案
  • 北美
  • 歐洲
  • 亞太地區
  • 其他的國家 (RoW)

第8章 終端用戶方面的認識

第9章 企業簡介

目錄
Product Code: MD20

North America was the largest market for NIPT in 2016 in terms of revenue and volume. The region is expected to retain its leadership position throughout the forecast period as major players in the NIPT market are based in the U.S. (the largest shareholder in North America).

Non-invasive prenatal testing (NIPT) is an innovative way of screening pregnancies for fetal chromosomal aneuploidies by analyzing fetal cell-free DNA circulating in maternal blood. Amniocentesis, chorionic villus sampling (CVS), maternal serum screening, and nuchal translucency (NT) scan have been the primary diagnostic and screening methods for chromosomal abnormalities. The growth of NIPT market is attributed primarily to a rapid increase in genetic disorders/abnormalities, increase in fetal mortality, adoption of NIPT test in developed countries, and advancement of healthcare technologies.

In spite of enormous competition levels that prevails in the industry, the market growth is expected to be propelled by multiple factors such as rising demand for prenatal testing, adoption toward IVF procedures, increasing awareness among parents, and upsurge in the government spending on healthcare.

The research study has segmented the entire NIPT market into test value and volume, and geographical region including detail country analysis which enables the user gain a multi-dimensional view of the market. The research report employs an exhaustive and analytical approach to estimate and understand the market thus provides an all-inclusive insight into various forms of developments, market trends and strategies. While underlining the key driving and restraining factors for the NIPT market, the report also provides a comprehensive understanding in terms of competitive landscape, market share analysis, competitor benchmarking (matrices), and their positioning within the global NIPT market.

The following questions have been answered in this report:

  • What are the major market drivers, challenges and opportunities of the global NIPT market and their use cases?
  • What are the key technological developments taking place in the NIPT market?
  • What is the market share of the leading segments and sub-segments of the global NIPT market during the forecast period (2017-2023)?
  • How will each segment of the global NIPT market grow over the forecast period and the revenue share for each of them by the end of 2023?
  • Who are the leading players in the global NIPT market (2016)?
  • Which geographical region will have the highest growth rate (CAGR) during the forecast period?
  • What are the key development strategies employed by the key players across various geographies?
  • What are the market trends and key developments in different geographical regions?
  • What is the role of various regulatory and governmental agencies in global NIPT market across various geographical locations?
  • What are the major consumer preferences while purchasing or undergoing an NIPT test?

The report includes the company profiles for leading players in the NIPT market which enables the readers understand the current competitive scenario that prevails in this industry. Some of the key player include Roche, Natera, Illumina, LabCorp, LifeCodexx, BGI Diagnostics, Premaitha and Berry Genomics, among others.

Table of Contents

Executive Summary

1. Report Scope & Methodology

  • 1.1. Scope of the Report
  • 1.2. Global NIPT Market Segmentation
  • 1.3. Key Learnings
  • 1.4. Research Methodology
    • 1.4.1. Data Triangulation
    • 1.4.2. Key Data Points from Secondary Sources
    • 1.4.3. Key Data Points from Primary Sources
    • 1.4.4. Top-Down Approach (Segment Analysis)
    • 1.4.5. Bottom-Up-Approach (Segment Analysis)
    • 1.4.6. Assumptions and Limitations
    • 1.4.7. Data and Prediction Modelling

2. Market Overview

  • 2.1. Introduction
  • 2.2. Benefits and Risks of NIPT
  • 2.3. Technological Approach for NIPT
    • 2.4.1. Fetal Cell Maternal Blood (FCMB)
    • 2.4.2. Cell-Free NIPT Test
  • 2.5. Patent Landscape
  • 2.6. World Economic Outlook of Prenatal Testing Market, 2016

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

4. Major Chromosomal Aneuploidies

5. Competitive Landscape

  • 5.1. Key Developments & Strategies
  • 5.2. Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
  • 5.3. Growth Share Matrix
  • 5.4. Porter's Five Forces Analysis
  • 5.5. Value Chain Analysis

6. Global NIPT Market, By Test (Volume and Value)

  • 6.1. Market Overview
  • 6.2. Panorama Test
  • 6.3. Sequenom Test
  • 6.4. Harmony Test
  • 6.5. NIFTY Test
  • 6.6. verifi Test
  • 6.7. IONA Test
  • 6.8. Prena Test
  • 6.9. BambniTest
  • 6.1. Other NIPT Tests

7. Global NIPT Market, By Geography(Volume and Value)

  • 7.1. Geographical Scenario
  • 7.2. North America
  • 7.3. Europe
  • 7.4. Asia Pacific
  • 7.5. Rest of the World (RoW)

8. End User Perception

9. Company Profiles

  • 9.1. Laboratory Corporation of America
  • 9.2. Roche AG
  • 9.3. Premaitha Health Plc
  • 9.4. Illumina Inc.
  • 9.5. Natera Inc.
  • 9.6. Quest Diagnostics
  • 9.7. BGI Diagnostics
  • 9.8. LifeCodexx AG
  • 9.9. Berry Genomics
  • 9.10. NIPD Genetics

LIST OF FIGURES

  • 1 Global NIPT Market by Volume, 2016-2023 (in Units)
  • 2 Global NIPT Market Value, 2016-2023 ($Million)
  • 3 NIPT Market Value by Test Type, 2016
  • 4 NIPT Market Value by Test Type, 2023
  • 5 NIPT Market Volume by Test Type, 2016
  • 6 NIPT Market Volume by Test Type, 2023
  • 7 Global NIPT Market Value by Geography, 2016 & 2023 ($Million)
  • 8 Global NIPT Market Volume by Geography, 2016 & 2023 (in Units)
  • 9 Global NIPT Market Segmentation
  • 10 Research Methodology
  • 11 Data Triangulation
  • 12 Top-Down Approach (Segmental Analysis)
  • 13 Bottom-Up Approach (Segmental Analysis)
  • 14 Assumptions and Limitations
  • 15 NIPT: Overall Process
  • 16 Global Prenatal Testing Market: Opportunity Matrix
  • 17 Ecosystem Players Of Global Prenatal Testing Market
  • 18 Prenatal Testing Timeline During Pregnancy
  • 19 Market Dynamics
  • 20 Market Share Analysis, 2016
  • 21 Market Share Analysis, 2023
  • 22 Growth Share Matrix, 2016
  • 23 Porter's Five Forces Analysis
  • 24 Value Chain Analysis
  • 25 Panorama Test by Volume, 2016-2023 (in Units)
  • 26 Panorama Test by Value, 2016-2023 ($Million)
  • 27 Panorama Test Volume by Geography, 2016-2023 (in Units)
  • 28 Sequenom Test by Volume, 2016-2023 (in Units)
  • 29 Sequenom Test by Value, 2016-2023 ($Million)
  • 30 Sequenom Test Volume by Geography, 2016-2023 (in Units)
  • 31 Sequenom Test Value by Geography, 2016-2023 ($Million)
  • 32 Harmony Test by Volume, 2016-2023 (in Units)
  • 33 Harmony Test by Value, 2016-2023 ($Million)
  • 34 Harmony Test Volume by Geography, 2016-2023 (in Units)
  • 35 Harmony Test Value by Geography, 2016-2023 ($Million)
  • 36 NIFTY Test by Volume, 2016-2023 (in Units)
  • 37 NIFTY Test by Value, 2016-2023 ($Million)
  • 38 NIFTY Test Volume by Geography, 2016-2023 (in Units)
  • 39 NIFTY Test Value by Geography, 2016-2023 ($Million)
  • 40 verifi Test by Volume, 2016-2023 (in Units)
  • 41 verifi Test by Value, 2016-2023 ($Million)
  • 42 verifi Test Volume by Geography, 2016-2023 (in Units)
  • 43 verifi Test Value by Geography, 2016-2023 ($Million)
  • 44 IONA Test by Volume, 2016-2023 (in Units)
  • 45 IONA Test by Value, 2016-2023 ($Million)
  • 46 IONA Test Volume by Geography, 2016-2023 (in Units)
  • 47 IONA Test Value by Geography, 2016-2023 ($Million)
  • 48 Prena Test by Volume, 2016-2023 (in Units)
  • 49 Prena Test by Value, 2016-2023 ($Million)
  • 50 Prena Test Volume by Geography, 2016-2023 (in Units)
  • 51 Prena Test Value by Geography, 2016-2023 ($Million)
  • 52 BambniTest by Volume, 2016-2023 (in Units)
  • 53 BambniTest by Value, 2016-2023 ($Million)
  • 54 BambniTest Volume by Geography, 2016-2023 (in Units)
  • 55 BambniTest Value by Geography, 2016-2023 ($Million)
  • 56 Other NIPT Tests by Volume, 2016-2023 (in Units)
  • 57 Other NIPT Tests by Value, 2016-2023 ($Million)
  • 58 Other NIPT Tests Volume by Geography, 2016-2023 (in Units)
  • 59 Other NIPT Tests Value by Geography, 2016-2023 ($Million)
  • 60 NIPT Market Value by Geography, 2016-2023 ($Million)
  • 61 NIPT Market Volume by Geography, 2016-2023 (in Units)
  • 62 Key Factors Influencing Decision about NIPT Market
  • 63 Influence of GPs, Labs, and KOLs on Decision Making
  • 64 Willingness to Purchase NIPT Tests
  • 65 Technology Preferences
  • 66 Perception about Pricing
  • 67 Perception about Brand
  • 68 Selection Criteria for NIPT Tests
  • 69 Sources of Information about NIPT
  • 70 Information Required to Purchase a new Test
  • 71 Preferred Channel for Purchasing
  • 72 Laboratory Corporation of America Financials
  • 73 Roche AG Financials
  • 74 Premaitha Health Plc Financials
  • 75 Illumina Inc. Financials
  • 76 Natera Inc. Financials
  • 77 Quest Diagnostics Incorporated Financials

LIST OF FIGURES

  • 1 Table: Global Non-Invasive Prenatal Testing (NIPT) Market (2016 & 2023)
  • 2 Table: Technological Approach for NIPT
  • 3 Table: Patent Landscape
  • 4 Table: Types Of Genetic Diseases In Fetuses: An Overview
  • 5 Table: Major Chromosomal Aneuploidies and their Incidence Rate
  • 6 Table: Recent Partnerships & Collaborations
  • 7 Table: Recent Product Launch & Developments
  • 8 Table: Recent Merger & Acquisitions
  • 9 Table: Recent Patent , Certifications, Infringements & Approvals
  • 10 Table: Global NIPT Market Value by Test Type, 2016-2013 (In Units)
  • 11 Table: North America Market Scope Statistics
  • 12 Table: North America NIPT Market by Test Value, 2016-2023 ($Million)
  • 13 Table: Europe NIPT Market by Test Value, 2016-2023 ($Million)
  • 14 Table : Europe NIPT Market by Test Volume, 2016-2023 (in Units)
  • 15 Table: Europe NIPT Market by Country, 2016-2023 (in Units)
  • 16 Table: Europe: Recent Developments
  • 17 Table: APAC NIPT Market by Test Volume, 2016-2023 ($Million)
  • 18 Table: APAC NIPT Market by Test Value, 2016-2023 (in Units)
  • 19 Table : APAC NIPT Market by Country, 2016-2023 (in Units)
  • 20 Table: ROW NIPT Market by Test value, 2015-2023 (in Units)
  • 21 Table: ROW NIPT Market by Test Volume, 2015-2023 (in Units)
Back to Top